Clinical Trial Update: A Novel Haemostatic Agent for Robotic Partial Nephrectomy [NA]

View source ↗

Summary

A clinical trial evaluating a novel haemostatic agent for robotic partial nephrectomy has been withdrawn from ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Renal Cell Carcinoma

Snippet

Sponsor: The Royal Wolverhampton Hospitals NHS Trust | Conditions: Kidney Cancer, Renal Cell Carcinoma | NA | Status: WITHDRAWN